Results 171 to 180 of about 7,404 (210)

Association of Risk-Reducing Salpingo-Oophorectomy With Breast Cancer Risk in Women With BRCA1 and BRCA2 Pathogenic Variants.

JAMA Oncol, 2021
Choi YH, Terry MB, Daly MB, MacInnis RJ, Hopper JL, Colonna S, Buys SS, Andrulis IL, John EM, Kurian AW, Briollais L.   +10 more
europepmc   +1 more source

Health Care Provider Adherence to Surgical Guidelines for Risk-Reducing Salpingo-Oophorectomy. [PDF]

Obstet Gynecol, 2019
Wilhite AM, Oestreich MC, Olson M, Bedell SM, Westenberg D, Bangdiwala A, Ikramuddin S, Sanchez-Avila M, Madoff RD, Khalifa MA, Erickson BK.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Prevalence of sexual dysfunction after risk-reducing salpingo-oophorectomy

Gynecologic Oncology, 2016
To determine the prevalence of sexual dysfunction in women after risk-reducing salpingo-oophorectomy (RRSO) and to assess factors which may influence sexual wellbeing following this procedure.This work is a cross-sectional study of women who underwent RRSO at a tertiary gynecologic oncology unit between January 2009 and October 2014.
Paige E. Tucker, Max K. Bulsara, Stuart G. Salfinger, Jason Jit-Sun Tan, Helena Green, Paul A. Cohen   +5 more
openaire   +4 more sources

Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy

Climacteric, 2009
The most effective strategy for prevention of ovarian and breast cancer in high-risk women is bilateral salpingo-oophorectomy. The inevitable consequence of the procedure is early menopause with the associated climacteric symptoms. Little is known about the nature of the symptoms in women who undergo risk-reducing bilateral salpingo-oophorectomy.To ...
A, Benshushan, N, Rojansky, M, Chaviv, S, Arbel-Alon, A, Benmeir, T, Imbar, A, Brzezinski   +6 more
openaire   +4 more sources

Risk-Reducing Salpingo-oophorectomy (RRSO)

2021
Risk-reducing salpingo-oophorectomy (RRSO) is performed for the primary prevention of ovarian cancer in patients with hereditary breast–ovarian cancer (HBOC) syndrome. When HBOC is diagnosed without ovarian cancer, surveillance is performed using transvaginal ultrasound and serum CA125 assessment, and chemoprophylaxis is administered using oral ...
Yusuke Kobayashi, Daisuke Aoki
openaire   +1 more source

Occult Tubal Carcinoma After Risk-Reducing Salpingo-oophorectomy

Obstetrics & Gynecology, 2020
OBJECTIVE: To perform a systematic review of the literature to estimate the prevalence and outcomes of occult tubal carcinoma in BRCA mutation carriers and high-risk patients undergoing risk-reducing salpingo-oophorectomy. DATA SOURCE: A search was done using OVID MEDLINE, EMBASE ...
Sabrina, Piedimonte, Cairina, Frank, Claudie, Laprise, Andrea, Quaiattini, Walter H, Gotlieb   +4 more
openaire   +2 more sources

Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers

Archives of Gynecology and Obstetrics, 2010
Risk-reducing salpingo-oophorectomy (RRSO) is often recommended to carriers of deleterious breast cancer gene 1/2 (BRCA1/2) mutations in order to reduce their breast cancer risk by 50% and their ovarian cancer risk by approximately 95%. To evaluate the acceptance, timing, histopathology findings and follow-up results we retrospectively analyzed a ...
Kerstin, Rhiem, Dolores, Foth, Barbara, Wappenschmidt, Heidrun, Gevensleben, Reinhard, Büttner, Uwe, Ulrich, Rita K, Schmutzler   +6 more
openaire   +2 more sources

Prophylactic and Risk-Reducing Bilateral Salpingo-oophorectomy

Obstetrics & Gynecology, 2010
Women who do not have a documented germline mutation or who do not have a strong family history suspicious for a germline mutation are considered to be at average risk of ovarian cancer. Women who have confirmed deleterious BRCA1 and BRCA2 germline mutations are high risk of ovarian cancer.
Jonathan S, Berek, Eva, Chalas, Mitchell, Edelson, David H, Moore, William M, Burke, William A, Cliby, Andrew, Berchuck   +6 more
openaire   +2 more sources

Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy

American Journal of Obstetrics and Gynecology, 2006
The purpose of this study was to define the rate of neoplasia in prophylactic surgical specimens with the use of a careful surgical and pathologic protocol in a prospective study of high-risk women who were undergoing risk-reducing salpingo-oophorectomy. Outcomes of interest were neoplasia that was identified in surgical specimens and clinical outcomes
Julie D, Lamb, Rochelle L, Garcia, Barbara A, Goff, Pamela J, Paley, Elizabeth M, Swisher   +4 more
openaire   +2 more sources

Risk-Reducing Bilateral Salpingo-Oophorectomy and Sexual Health: A Qualitative Study

Journal of Obstetrics and Gynaecology Canada, 2012
To examine the impact of risk-reducing bilateral salpingo-oophorectomy (RRBSO) on sexual function in BRCA gene mutation carriers, compared with the effect on women undergoing BSO (bilateral salpingo-oophorectomy) for benign indications from a qualitative perspective.Our study included 25 women who had undergone either a RRBSO because of BRCA carrier ...
Lori A, Brotto, Nadia, Branco, Cara, Dunkley, Mary, McCullum, Jessica N, McAlpine   +4 more
openaire   +2 more sources